Skip to main content
. 2020 Jan 3;11:15. doi: 10.1038/s41467-019-13831-w

Fig. 1. Study design and data integration.

Fig. 1

We conducted an EWAS with proteomics in KORA and replicated the associations in QMDiab (see Fig. 2). We used Ingenuity Pathway Analysis (IPA) to connect CpG-linked genes to their associated proteins through literature-reported observations and complemented the network with associations to gene expression (BIOS), metabolomics (QMDiab), and clinical endpoints (KORA), finally adding all previously reported disease associations. The resulting networks, using the same color code as here, are presented in Figs. 3 and 4.